Results 301 to 310 of about 2,513,925 (427)

Differential Agonist Regulation of the Human κ‐Opioid Receptor [PDF]

, 1997
Allan D. Blake, George Bot, Shuixing Li, John Freeman, Terry Reisine   +4 more
openalex   +1 more source

Environmental life cycle of fentanyl: From the cradle to an unknown grave

Journal of Environmental Quality, EarlyView.
Abstract The lack of available information on the presence and persistence of fentanyl in the environment is a significant gap in the technical literature. Although the origins of the opioid in the environment are well‐known because they follow the same pathways of other drug‐related environmental contaminants, the downstream effects of fentanyl in the
Deseree J. Reid, Kaizad F. Patel, Angela M. Melville, Vanessa L. Bailey, Kristin M. Omberg, Loreen R. Lamoureux   +5 more
wiley   +1 more source

Endogenous opioid receptor system mediates costly altruism in the human brain. [PDF]

Commun Biol
Chen J, Putkinen V, Seppälä K, Hirvonen J, Ioumpa K, Gazzola V, Keysers C, Nummenmaa L.   +7 more
europepmc   +1 more source

Characterization of δ, κ, and μ Human Opioid Receptors Overexpressed in Baculovirus-infected Insect Cells [PDF]

, 1997
Dominique Massotte, Laurence Baroche, Frédéric Simonin, Lei Yu, Brigitte L. Kieffer, Franc Pattus   +5 more
openalex   +1 more source

Butorphanol or a Combination of Ketamine and Xylazine Do Not Interfere With Arrhythmogenic Parameters in Agoutis (Dasyprocta prymnolopha) Obtained Through High‐Resolution Electrocardiogram

Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, EarlyView.
ABSTRACT Introduction/Objectives: Agoutis is a medium‐sized wild rodent with potential for use as an experimental model. This study aimed to evaluate physiological parameters of arrhythmogenesis in this species, by HR‐ECG and VCG techniques, under physical and pharmacological containment (ketamine‐xylazine and butorphanol). Materials and methods: Eight
Charlys Rhands Coelho de Moura, Hermínio José da Rocha Neto, Regina Lucia dos Santos Silva, Nayla Maria da Silva Rezende Amorim, José Lindenberg Rocha Sarmento, Miguel Ferreira Cavalcante Filho, Wanderson Gabriel Gomes de Melo, Dayseanny de Oliveira Bezerra, Maria Acelina Martins Carvalho, Napoleão Martins Argolo Neto   +9 more
wiley   +1 more source

Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects. [PDF]

Molecules
van de Wetering R, Vu LY, Kornberger LD, Luo D, Scouller B, Hong S, Paton K, Prisinzano TE, Kivell BM.   +8 more
europepmc   +1 more source

Reversion of muscarinic autoreceptor agonist‐induced acetylcholine decrease and learning impairment by dynorphin A (1–13), an endogenous κ‐opioid receptor agonist [PDF]

, 1998
Masayuki Hiramatsu, Hiroyasu Murasawa, Hiromasa Mori, Tsutomu Kameyama   +3 more
openalex   +1 more source

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

Nature, 1995
J. Meunier, C. Mollereau, L. Toll, C. Suaudeau, C. Moisand, P. Alvinerie, J. Butour, J. Guillemot, P. Ferrara, B. Monsarrat, H. Mazarguil, G. Vassart, M. Parmentier, J. Costentin   +13 more
semanticscholar   +1 more source

Systematic in‐hospital screening and treatment for osteoporosis in a geriatric population with hip fractures

Journal of Hospital Medicine, EarlyView.
Abstract Background Low‐trauma fractures of the hip signify osteoporosis and increase the risk of a second fracture. However, screening for secondary osteoporosis and initiating osteoporosis treatment can be challenging in a geriatric population.
Jeppe B. Rosenbæk, Line B. Dalgaard, Anne Grauballe, Stella J. Wilfred, Mikkel W. Ibsen, Lene R. Madsen   +5 more
wiley   +1 more source

A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)? [PDF]

Pharmaceuticals (Basel)
Schreiber S, Keidan L, Pick CG.
europepmc   +1 more source